Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrity Investor Relations is a boutique investor relations firm that provides strategic advisory and communication services to micro-cap and small-cap companies, with a specialized focus on the life sciences and healthcare industries. The firm assists emerging growth companies in building visibility within the investment community and managing complex shareholder communications. Their service offerings include investor targeting, earnings call preparation, and the development of strategic messaging for clinical and regulatory milestones. By leveraging deep industry expertise, Integrity Investor Relations helps its clients navigate the capital markets and establish long-term credibility with institutional and retail investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrity Investor Relations.